HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joel Pearlman Selected Research
Joel Pearlman Research Topics
Disease
2
Retinal Vasculitis
07/2021 - 07/2020
2
Inflammation (Inflammations)
07/2021 - 07/2020
2
Macular Degeneration (Age-Related Maculopathy)
07/2020 - 01/2017
1
Choroidal Neovascularization
01/2017
1
Edema (Dropsy)
01/2014
1
Retinal Vein Occlusion
01/2014
1
Diabetic Retinopathy (Retinopathy, Diabetic)
10/2006
1
Diabetes Mellitus
10/2006
1
Ischemia
03/2002
1
Retinal Neovascularization
03/2002
Drug/Important Bio-Agent (IBA)
2
brolucizumab
IBA
07/2021 - 07/2020
2
Ranibizumab (Lucentis)
FDA Link
01/2017 - 01/2014
2
Retinaldehyde (Retinal)
IBA
10/2006 - 03/2002
1
Anti-Bacterial Agents (Antibiotics)
IBA
07/2021
1
Verteporfin (Visudyne)
FDA Link
01/2017
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2017
1
Fluorescein (Funduscein)
FDA Link
Generic
10/2006
1
Bevacizumab (Avastin)
FDA Link
10/2006
1
Biological Products
IBA
10/2006
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2002
1
pigment epithelium-derived factor
IBA
03/2002
Therapy/Procedure
1
Aftercare (After-Treatment)
07/2020
1
Therapeutics
01/2017
1
Photochemotherapy (Photodynamic Therapy)
01/2017
1
Injections
01/2014
1
Lasers (Laser)
01/2014
1
Light Coagulation
01/2014